A recent study (n = 429) further highlighted the potential of serum NFL to distinguish ALS from other diseases, implying that the routine examination of serum NFL can improve survival prediction and diagnostic accuracy [188]. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.